CLOs on the Move

Aletheia Therapy

www.aletheiadfw.com

 
Aletheia Therapy is a group of clinicians dedicated to providing the highest quality psychotherapy and counseling services. They work collaboratively as a practice in order to draw on each therapist’s unique perspective and expertise to most effectivel...
  • Number of Employees: 0-25
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Mercury Medical

Mercury Medical is a Clearwater, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Before Brands Inc

Before Brands is a health and wellness company that is developing a series of products targeted at transforming the world`s relationship with food allergies. The science behind each of our products is our proprietary Early Adaptive Training (E.A.T.) protein blend that was developed at Stanford University by a pediatrician, allergist and Mother of five.

TB12

TB12 is transforming health by empowering athletes everywhere to improve longevity, prevent injury, and do what they love better and for longer. Our holistic approach to health & wellness includes adequate hydration, mainly plant-based nutrition, funct...

Neurotrope Inc

Neurotrope was formed in October 2012 to develop and market two product platforms, including a non-invasive diagnostic test for Alzheimer's Disease and a drug candidate called bryostatin for the treatment of Alzheimer's Disease, both of which are in the clinical testing stage.  Neurotrope was formed for the primary purpose of commercializing certain technologies that were initially developed by Blanchette Rockefeller Neurosciences Institute ("BRNI") and its affiliates, for therapeutic or diagnostic applications for Alzheimer's Disease or other cognitive dysfunctions.  These technologies have been under development since 1999 and have been financed through significant funding from a variety of non-investor sources. The Company expects that its first product, the diagnostic test for Alzheimer's Disease, will finish the testing phase of its development in 2015, whereupon the Company will evaluate the feasibility of its commercialization.  In addition to bryostatin and the diagnostic test for Alzheimer's Disease, the Company intends to pursue development of two other technology platforms developed by and licensed from BRNI: the first, a platform for transporting drugs into the brain through the "blood-brain-barrier," and the second, a group of drugs for enhancing cognition, mood and alertness for neuropsychiatric conditions.

CareOregon Advantage

CareOregon Advantage is a Portland, OR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.